These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1417 related items for PubMed ID: 16295558

  • 1. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 2. Treatment of non-small-cell lung cancer: the Chinese experience in a general teaching hospital.
    Chen YM, Chao JY, Tsai CM, Shiau CY, Liang MJ, Yen SH, Perng RP.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):459-66. PubMed ID: 10925536
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

  • 4. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):962-6. PubMed ID: 12899797
    [Abstract] [Full Text] [Related]

  • 5. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 10; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 6. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1438-43. PubMed ID: 16029805
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G, Moschopoulos N.
    Anticancer Res; 1999 Aug 01; 19(4C):3543-8. PubMed ID: 10629650
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM, Flentje M, Schmidt M, Pöllinger B, Gosse H, Willner J, Ulm K, Bronchial Carcinoma Therapy Group.
    J Clin Oncol; 2006 Sep 20; 24(27):4397-404. PubMed ID: 16983107
    [Abstract] [Full Text] [Related]

  • 9. Sequential combined modality therapy for stage III non-small cell lung cancer.
    Vokes EE.
    Hematol Oncol Clin North Am; 1990 Dec 20; 4(6):1133-42. PubMed ID: 1962780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA.
    Semin Oncol; 1994 Jun 20; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [Abstract] [Full Text] [Related]

  • 12. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group.
    J Thorac Cardiovasc Surg; 2004 Jul 20; 128(1):130-7. PubMed ID: 15224032
    [Abstract] [Full Text] [Related]

  • 13. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
    Yu DP, Bai LQ, Xu SF, Han M, Wang ZT.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 20; 31(6):465-8. PubMed ID: 19950561
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 20; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 15. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
    Eberhardt W, Stamatis G, Stuschke M, Wilke H, Müller MR, Kolks S, Flasshove M, Schütte J, Stahl M, Schlenger L, Budach V, Greschuchna D, Stüben G, Teschler H, Sack H, Seeber S.
    Br J Cancer; 1999 Dec 20; 81(7):1206-12. PubMed ID: 10584883
    [Abstract] [Full Text] [Related]

  • 16. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE, Morris DE, Moore DT, Bechtel JH, Halle JS, Mears A, Deschesne K, Rosenman JG, Socinski MA.
    Lung Cancer; 2006 Apr 20; 52(1):67-74. PubMed ID: 16499996
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.
    Butts C, Murray N, Maksymiuk A, Goss G, Marshall E, Soulières D, Cormier Y, Ellis P, Price A, Sawhney R, Davis M, Mansi J, Smith C, Vergidis D, Ellis P, MacNeil M, Palmer M.
    J Clin Oncol; 2005 Sep 20; 23(27):6674-81. PubMed ID: 16170175
    [Abstract] [Full Text] [Related]

  • 18. Lung cancer and its operable brain metastasis: survival rate and staging problems.
    Furák J, Troján I, Szöke T, Agócs L, Csekeö A, Kas J, Svastics E, Eller J, Tiszlavicz L.
    Ann Thorac Surg; 2005 Jan 20; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N, Pedersen LM.
    Oncol Rep; 2002 Jan 20; 9(1):193-8. PubMed ID: 11748482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.